Innovative Clinical or Translational Science Award – Aging in Diabetes RFA (2026)
Supports innovative clinical or translational research to improve prevention, diagnosis, or treatment of diabetes in older adults through impactful, human-focused studies.
Funder: American Diabetes Association
Due Dates (Anticipated): December 2026 (Letter of Intent) | February 2027 (Full proposal)
Funding Amounts: Up to $200,000/year (including 10% indirect costs), max $600,000 over 3 years
Summary: Funds innovative clinical or translational research to improve prevention, diagnosis, and treatment of diabetes in older adults, emphasizing impactful, human-centered studies.
Description
This grant supports clinical or translational research projects that directly involve human subjects, samples, or data, with a strong potential to advance the cure, prevention, or treatment of diabetes in older adults. The program is part of the American Diabetes Association's Aging in Diabetes RFA and aims to address the unique challenges and disease burden faced by older individuals living with diabetes. Projects should focus on innovative approaches that improve prevention, diagnosis, and treatment strategies, with a clear impact on outcomes relevant to this population.
